Results 191 to 200 of about 165,036 (300)

Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes. [PDF]

iScience, 2022
Wu Q, Kumar N, Lafuse WP, Ahumada OS, Saljoughian N, Whetstone E, Zani A, Patton AK, El Refaey M, Webb A, Pietrzak M, Yu L, Kc M, Peeples ME, Ganesan LP, Yount JS, Rajaram MVS.   +16 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

MitoQ Protects Against Oxidative Stress-Induced Mitochondrial Dysregulation in Human Cardiomyocytes. [PDF]

J Mol Cell Cardiol Plus
Parker AM, Lees JG, Tate M, Phang RJ, Velagic A, Deo M, Bishop T, Krieg T, Murphy MP, Lim SY, De Blasio MJ, Ritchie RH.   +11 more
europepmc   +1 more source

Stem cells for the heart, are we there yet? [PDF]

, 2003
De Sutter, Johan, Gillebert, Thierry, Timmermans, Frank   +2 more
core   +2 more sources

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Mitochondrial Protection by Astaxanthin Reduces Toxicity Caused by H₂O₂ and Doxorubicin in Human Cardiomyocytes. [PDF]

Cells
Baburina Y, Lomovsky A, Lomovskaya Y, Sotnikov R, Sotnikova L, Krestinina O.   +5 more
europepmc   +1 more source

Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells. [PDF]

Int J Mol Sci, 2023
Salvarani N, Peretto G, Silvia C, Villatore A, Thairi C, Santoni A, Galli C, Carrera P, Sala S, Benedetti S, Di Pasquale E, Di Resta C.   +11 more
europepmc   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Per- and Polyfluoroalkyl Substances Induce Cardiotoxicity and Alter Protein Profiles of Extracellular Matrix, Metabolism, and Mitochondrial Function in Human Cardiomyocytes. [PDF]

Chem Res Toxicol
Zhang W, Wang Z, Reid O, Harris F, Man K, Wang M, Li S, Armand LC, Lane A, Patel G, Faundez V, Du Y, Wu R, Brown LA, Caudle WM, Xu C.   +15 more
europepmc   +1 more source

Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes. [PDF]

Front Mol Biosci, 2022
Giannattasio S, Citarella A, Trocchianesi S, Filardi T, Morano S, Lenzi A, Ferretti E, Crescioli C.   +7 more
europepmc   +1 more source